Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ketamine in anorexia nervosa

To see complete record on, please visit this link

Id: ACTRN12618001393246p

Organisation Name: University of Otago

Overal Status: Not yet recruiting

Start Date: 02/09/2019

Brief Summary: We will investigate if patients with long-standing anorexia nervosa show improvements in mood, obsessionality ratings, or eating disorder cognitions after oral dosing with ketamine or midazolam, a psychoactive control. In the first 3 weeks, patient will receive one of 2 doses of ketamine, or a single dose of midazolam, under double-blind, crossover conditions. Patient who report improvements in depression or anxiety ratings will be eligible to enter a maintenance treatment phase, where they can receive oral ketamine 1-2 times weekly for 3 months.

  • New Zealand
  • Dunedin, Otago
  • anorexia nervosa
  • depressive disorder
  • anxiety disorder
  • obessional disorder

Total execution time in seconds: 0.30097079277039